LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 77

Search options

  1. Article: Notch and T Cell Function - A Complex Tale.

    Vijayaraghavan, Jyothi / Osborne, Barbara A

    Advances in experimental medicine and biology

    2018  Volume 1066, Page(s) 339–354

    Abstract: Notch drives critical decisions in a multitude of developmental decisions in many invertebrate and vertebrate organisms including flies, worms, fish, mice and humans. Therefore, it is not surprising that Notch family members also play a key role in cell ... ...

    Abstract Notch drives critical decisions in a multitude of developmental decisions in many invertebrate and vertebrate organisms including flies, worms, fish, mice and humans. Therefore, it is not surprising that Notch family members also play a key role in cell fate choices in the vertebrate immune system. This review highlights the critical function of Notch in the development of mature T lymphocytes from hematopoietic precursors and describes the role of Notch in mature T cell activation, proliferation and differentiation.
    MeSH term(s) Animals ; Cell Differentiation/immunology ; Cell Proliferation/physiology ; Hematopoietic Stem Cells/cytology ; Hematopoietic Stem Cells/immunology ; Humans ; Lymphocyte Activation ; Receptors, Notch/immunology ; Signal Transduction/immunology ; T-Lymphocytes/cytology ; T-Lymphocytes/immunology
    Chemical Substances Receptors, Notch
    Language English
    Publishing date 2018-07-20
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ISSN 2214-8019 ; 0065-2598
    ISSN (online) 2214-8019
    ISSN 0065-2598
    DOI 10.1007/978-3-319-89512-3_17
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Notch, a T-ALL order.

    Osborne, Barbara A

    Blood

    2011  Volume 117, Issue 10, Page(s) 2749–2750

    Language English
    Publishing date 2011-03-10
    Publishing country United States
    Document type Comment ; Journal Article
    ZDB-ID 80069-7
    ISSN 1528-0020 ; 0006-4971
    ISSN (online) 1528-0020
    ISSN 0006-4971
    DOI 10.1182/blood-2011-01-330225
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Protein-Antibody Conjugates (PACs): A Plug-and-Play Strategy for Covalent Conjugation and Targeted Intracellular Delivery of Pristine Proteins.

    Liu, Bin / Singh, Khushboo / Gong, Shuai / Canakci, Mine / Osborne, Barbara A / Thayumanavan, S

    Angewandte Chemie (International ed. in English)

    2021  Volume 60, Issue 23, Page(s) 12813–12818

    Abstract: We report here on protein-antibody conjugates (PACs) that are used for antibody-directed delivery of protein therapeutics to specific cells. PACs have the potential to judiciously combine the merits of two prolific therapeutic approaches-biologics and ... ...

    Abstract We report here on protein-antibody conjugates (PACs) that are used for antibody-directed delivery of protein therapeutics to specific cells. PACs have the potential to judiciously combine the merits of two prolific therapeutic approaches-biologics and antibody-drug conjugates. We utilize spherical polymer brushes to construct PACs using the combination of two simple and efficient functionally orthogonal click chemistries. In addition to the synthesis and characterization of these nanoparticles, we demonstrate that PACs are indeed capable of specifically targeting cells based on the presence of target antigen on the cell surface to deliver proteins. The potentially broad adaptability of PACs opens up new opportunities for targeted biologics in therapeutics and sensing.
    MeSH term(s) Antibodies/chemistry ; Cell Line, Tumor ; Fullerenes/chemistry ; Humans ; Nanoparticles/chemistry ; Particle Size ; Receptor, ErbB-2/chemistry
    Chemical Substances Antibodies ; Fullerenes ; pristine (C60) ; ERBB2 protein, human (EC 2.7.10.1) ; Receptor, ErbB-2 (EC 2.7.10.1)
    Language English
    Publishing date 2021-05-05
    Publishing country Germany
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2011836-3
    ISSN 1521-3773 ; 1433-7851
    ISSN (online) 1521-3773
    ISSN 1433-7851
    DOI 10.1002/anie.202103106
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Evaluation of Cellular Targeting by Fab' vs Full-Length Antibodies in Antibody-Nanoparticle Conjugates (ANCs) Using CD4 T-cells.

    Singh, Khushboo / Canakci, Mine / Kanjilal, Pintu / Williams, Natalie / Shanthalingam, Sudarvili / Osborne, Barbara A / Thayumanavan, S

    Bioconjugate chemistry

    2022  Volume 33, Issue 3, Page(s) 486–495

    Abstract: Targeted delivery of chemotherapeutic drugs can improve their therapeutic efficiency by localizing their toxic effects at the diseased site. This is often achieved either by direct conjugation of drugs to antibodies targeting overexpressed receptors on ... ...

    Abstract Targeted delivery of chemotherapeutic drugs can improve their therapeutic efficiency by localizing their toxic effects at the diseased site. This is often achieved either by direct conjugation of drugs to antibodies targeting overexpressed receptors on cancer cells (antibody-drug conjugates/ADCs) or by conjugating antibodies to nanoparticles bearing drugs (antibody-nanoparticle conjugates/ANCs). Here, we report a platform for utilizing hinge cysteines on antigen-binding fragment (Fab') of an anti-CD4 antibody for site-specific conjugation to nanoparticles giving rise to anti-CD4 Fab'-nanoparticle conjugates (Fab'-NCs). We demonstrate a convenient route for obtaining functional anti-CD4 Fab' from full-length antibody and examine the targeted delivery efficiencies of anti-CD4 Fab'-NCs vs ANCs for selective delivery to CD4
    MeSH term(s) Antibodies, Monoclonal ; CD4-Positive T-Lymphocytes ; Immunoconjugates ; Immunoglobulin Fab Fragments ; Nanoparticles
    Chemical Substances Antibodies, Monoclonal ; Immunoconjugates ; Immunoglobulin Fab Fragments
    Language English
    Publishing date 2022-02-09
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 1024041-x
    ISSN 1520-4812 ; 1043-1802
    ISSN (online) 1520-4812
    ISSN 1043-1802
    DOI 10.1021/acs.bioconjchem.2c00024
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: B-CLL kicks it up a Notch.

    Osborne, Barbara A

    Blood

    2009  Volume 113, Issue 4, Page(s) 765–766

    Language English
    Publishing date 2009-01-21
    Publishing country United States
    Document type Comment ; Journal Article
    ZDB-ID 80069-7
    ISSN 1528-0020 ; 0006-4971
    ISSN (online) 1528-0020
    ISSN 0006-4971
    DOI 10.1182/blood-2008-10-182998
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Non-canonical notch signaling in cancer and immunity.

    Ayaz, Furkan / Osborne, Barbara A

    Frontiers in oncology

    2014  Volume 4, Page(s) 345

    Abstract: Canonical Notch signaling is initiated by γ-secretase-mediated cleavage of the Notch receptor, leading to the release of the active intra-cellular domain of Notch that migrates to the nucleus and interacts with RBP-Jκ, resulting in the activation of ... ...

    Abstract Canonical Notch signaling is initiated by γ-secretase-mediated cleavage of the Notch receptor, leading to the release of the active intra-cellular domain of Notch that migrates to the nucleus and interacts with RBP-Jκ, resulting in the activation of downstream target genes. While canonical Notch signaling is well known to play an active role in several steps during development as well in multiple cell fate decisions, recent evidence from both invertebrate and vertebrate systems indicates that non-canonical, RBP-Jκ-independent signaling is important in several cellular processes including oncogenesis and activation of T lymphocytes. These observations raise the possibility that, through an understanding of non-canonical Notch signaling, novel strategies for inhibiting Notch signaling may prove useful in the design of therapies targeted to block aberrant Notch activity. In this mini-review, we will examine the current data demonstrating a non-canonical role for Notch signaling in both cancer and the immune system and suggest a better understanding of non-canonical signaling may reveal novel strategies to block Notch signaling in disease.
    Language English
    Publishing date 2014-12-04
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2649216-7
    ISSN 2234-943X
    ISSN 2234-943X
    DOI 10.3389/fonc.2014.00345
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Targeting Notch in oncology: the path forward.

    Majumder, Samarpan / Crabtree, Judy S / Golde, Todd E / Minter, Lisa M / Osborne, Barbara A / Miele, Lucio

    Nature reviews. Drug discovery

    2020  Volume 20, Issue 2, Page(s) 125–144

    Abstract: Notch signalling is involved in many aspects of cancer biology, including angiogenesis, tumour immunity and the maintenance of cancer stem-like cells. In addition, Notch can function as an oncogene and a tumour suppressor in different cancers and in ... ...

    Abstract Notch signalling is involved in many aspects of cancer biology, including angiogenesis, tumour immunity and the maintenance of cancer stem-like cells. In addition, Notch can function as an oncogene and a tumour suppressor in different cancers and in different cell populations within the same tumour. Despite promising preclinical results and early-phase clinical trials, the goal of developing safe, effective, tumour-selective Notch-targeting agents for clinical use remains elusive. However, our continually improving understanding of Notch signalling in specific cancers, individual cancer cases and different cell populations, as well as crosstalk between pathways, is aiding the discovery and development of novel investigational Notch-targeted therapeutics.
    MeSH term(s) Animals ; Antineoplastic Agents/administration & dosage ; Antineoplastic Agents/metabolism ; Drug Delivery Systems/methods ; Drug Delivery Systems/trends ; Humans ; Immunotherapy/methods ; Immunotherapy/trends ; Neoplasms/immunology ; Neoplasms/metabolism ; Neoplasms/therapy ; Neoplastic Stem Cells/drug effects ; Neoplastic Stem Cells/immunology ; Neoplastic Stem Cells/metabolism ; Receptors, Notch/immunology ; Receptors, Notch/metabolism ; Signal Transduction/drug effects ; Signal Transduction/physiology
    Chemical Substances Antineoplastic Agents ; Receptors, Notch
    Language English
    Publishing date 2020-12-08
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2062954-0
    ISSN 1474-1784 ; 1474-1776
    ISSN (online) 1474-1784
    ISSN 1474-1776
    DOI 10.1038/s41573-020-00091-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Exopolysaccharide-Treated Dendritic Cells Effectively Ameliorate Acute Graft-versus-Host Disease.

    Kalinina, Olga / Minter, Lisa M / Sperling, Anne I / Hollinger, Maile K / Le, Phong / Osborne, Barbara A / Zhang, Shubin / Stiff, Patrick / Knight, Katherine L

    Transplantation and cellular therapy

    2023  Volume 30, Issue 1, Page(s) 79.e1–79.e10

    Abstract: Graft-versus-host disease (GVHD) is a primary and often lethal complication of allogenic hematopoietic stem cell transplantation (HSCT). Prophylactic regimens for GVHD are given as standard pretransplantation therapy; however, up to 50% of these patients ...

    Abstract Graft-versus-host disease (GVHD) is a primary and often lethal complication of allogenic hematopoietic stem cell transplantation (HSCT). Prophylactic regimens for GVHD are given as standard pretransplantation therapy; however, up to 50% of these patients develop acute GVHD (aGVHD) and require additional immunosuppressive intervention. Using a mouse GVHD model, we previously showed that injecting mice with exopolysaccharide (EPS) from Bacillus subtilis prior to GVHD induction significantly increased 80-day survival after transplantation of complete allogeneic major histocompatibility complex-mismatched cells. To ask whether EPS might also inhibit GVHD in humans, we used humanized NSG-HLA-A2 mice and induced GVHD by i.v. injection of A2
    MeSH term(s) Animals ; Humans ; Transplantation, Homologous/adverse effects ; HLA-A2 Antigen ; Leukocytes, Mononuclear ; Graft vs Host Disease/prevention & control ; Disease Models, Animal ; Dendritic Cells
    Chemical Substances HLA-A2 Antigen
    Language English
    Publishing date 2023-11-02
    Publishing country United States
    Document type Journal Article
    ZDB-ID 3062231-1
    ISSN 2666-6367
    ISSN (online) 2666-6367
    DOI 10.1016/j.jtct.2023.10.023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: LKB1 isoform expression modulates T cell plasticity downstream of PKCθ and IL-6.

    Mohan, Deeksha / Sherman, Heather L / Mitra, Ankita / Lawlor, Rebecca / Shanthalingam, Sudarvili / Ullom, Jacob / Pobezinskaya, Elena L / Zhang, Guodong / Osborne, Barbara A / Pobezinsky, Leonid A / Tew, Gregory N / Minter, Lisa M

    Molecular immunology

    2023  Volume 157, Page(s) 129–141

    Abstract: Following activation, CD4 T cells undergo metabolic and transcriptional changes as they respond to external cues and differentiate into T helper (Th) cells. T cells exhibit plasticity between Th phenotypes in highly inflammatory environments, such as ... ...

    Abstract Following activation, CD4 T cells undergo metabolic and transcriptional changes as they respond to external cues and differentiate into T helper (Th) cells. T cells exhibit plasticity between Th phenotypes in highly inflammatory environments, such as colitis, in which high levels of IL-6 promote plasticity between regulatory T (Treg) cells and Th17 cells. Protein Kinase C theta (PKCθ) is a T cell-specific serine/threonine kinase that promotes Th17 differentiation while negatively regulating Treg differentiation. Liver kinase B1 (LKB1), also a serine/threonine kinase and encoded by Stk11, is necessary for Treg survival and function. Stk11 can be alternatively spliced to produce a short variant (Stk11
    MeSH term(s) Protein Kinase C-theta/metabolism ; Interleukin-6/metabolism ; Cell Plasticity ; Protein Serine-Threonine Kinases/genetics ; Protein Serine-Threonine Kinases/metabolism ; CD4-Positive T-Lymphocytes/metabolism ; T-Lymphocytes, Regulatory/metabolism ; Cell Differentiation ; Protein Isoforms/metabolism ; Th17 Cells/metabolism
    Chemical Substances Protein Kinase C-theta (EC 2.7.11.13) ; Interleukin-6 ; Protein Serine-Threonine Kinases (EC 2.7.11.1) ; Protein Isoforms
    Language English
    Publishing date 2023-04-03
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 424427-8
    ISSN 1872-9142 ; 0161-5890
    ISSN (online) 1872-9142
    ISSN 0161-5890
    DOI 10.1016/j.molimm.2023.03.020
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Targeting CD4⁺ Cells with Anti-CD4 Conjugated Mertansine-Loaded Nanogels

    Canakci, Mine / Singh, Khushboo / Munkhbat, Oyuntuya / Shanthalingam, Sudarvili / Mitra, Ankita / Gordon, Mallory / Osborne, Barbara A / Thayumanavan, S

    Biomacromolecules. 2020 May 08, v. 21, no. 6

    2020  

    Abstract: CD4⁺ T lymphocytes play an important role in controlling many malignancies. The modulation of CD4⁺ T cells through immunomodulatory or cytotoxic drugs could change the course of disease progression for disorders such as autoimmunity, immunodeficiency, ... ...

    Abstract CD4⁺ T lymphocytes play an important role in controlling many malignancies. The modulation of CD4⁺ T cells through immunomodulatory or cytotoxic drugs could change the course of disease progression for disorders such as autoimmunity, immunodeficiency, and cancer. Here, we demonstrate that anti-CD4 conjugated polymeric nanogels can deliver a small molecule cargo to primary CD4⁺ T cells and a CD4ʰⁱᵍʰ T cell lymphoma. The antibody conjugation not only increased the uptake efficiency of the nanogel (NG) by CD4⁺ T cells but also decreased the non-specific uptake of the NG by CD4– lymphocytes. For T lymphoma cell lines, the mertansine-loaded conjugate displayed a dose-dependent cell growth inhibition at 17 ng/mL antibody concentration. On the other hand, antibody-drug conjugate (ADC)-type formulation of the anti-CD4 reached similar levels of cell growth inhibition only at the significantly higher concentration of 1.8 μg/mL. NG and antibody conjugates have the advantage of carrying a large payload to a defined target in a more efficient manner as it needs far less antibody to achieve a similar outcome.
    Keywords T-cell lymphoma ; antibodies ; autoimmunity ; cell growth ; cytotoxicity ; disease progression ; dose response ; growth retardation ; immunosuppression ; nanogels ; neoplasm cells ; polymers
    Language English
    Dates of publication 2020-0508
    Size p. 2473-2481.
    Publishing place American Chemical Society
    Document type Article
    Note NAL-AP-2-clean
    ISSN 1526-4602
    DOI 10.1021/acs.biomac.0c00442
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

To top